Published in Evid Based Complement Alternat Med on May 18, 2014
Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol (2014) 1.00
Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int (2014) 0.94
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells. Int J Biol Sci (2015) 0.92
Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evid Based Complement Alternat Med (2016) 0.80
Spices for Prevention and Treatment of Cancers. Nutrients (2016) 0.78
Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Drug Des Devel Ther (2016) 0.77
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. J Ovarian Res (2015) 0.76
Killing cancer with platycodin D through multiple mechanisms. J Cell Mol Med (2015) 0.76
Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways. Int J Clin Exp Pathol (2015) 0.76
Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer. Mol Cancer (2015) 0.75
Methylferulate from Tamarix aucheriana inhibits growth and enhances chemosensitivity of human colorectal cancer cells: possible mechanism of action. BMC Complement Altern Med (2016) 0.75
Aloe vera: Potential candidate in health management via modulation of biological activities. Pharmacogn Rev (2015) 0.75
Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive. J Ayurveda Integr Med (2016) 0.75
Potential Antitumor Effects of Pomegranates and Its Ingredients. Pharmacogn Rev (2017) 0.75
Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro. Sci Rep (2017) 0.75
Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget (2017) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
The development of androgen-independent prostate cancer. Nat Rev Cancer (2001) 11.88
Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science (1987) 8.36
Arachidonic acid metabolism. Annu Rev Biochem (1986) 6.56
The role of STATs in transcriptional control and their impact on cellular function. Oncogene (2000) 6.42
Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med (1998) 5.16
Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc (1996) 4.62
Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med (1990) 4.06
Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer (1994) 3.38
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res (2006) 3.01
Pharmacological and toxicological properties of Nigella sativa. Phytother Res (2003) 2.78
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res (1998) 2.67
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol (2004) 2.45
Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc Natl Acad Sci U S A (1998) 2.44
Natural products for cancer prevention: a global perspective. Pharmacol Ther (2003) 2.01
Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate (2004) 1.96
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res (2001) 1.93
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88
Rel/NF-kappa B/I kappa B story. Adv Cancer Res (1995) 1.83
The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res (1998) 1.81
Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J Cancer (2003) 1.80
Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res (2000) 1.80
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol (2002) 1.76
Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol (2011) 1.76
The role of herbs and spices in cancer prevention. J Nutr Biochem (2008) 1.73
High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal (1999) 1.69
The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol (1999) 1.65
p21--negative regulator of the cell cycle. Proc Soc Exp Biol Med (1996) 1.61
Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol (2004) 1.60
Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res (2008) 1.58
Phorbol-ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex. Cold Spring Harb Symp Quant Biol (1988) 1.55
Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther (2008) 1.55
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (2000) 1.51
COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol (2005) 1.45
Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad (2009) 1.45
From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther (2008) 1.43
Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer (2005) 1.41
Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol (2003) 1.39
Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res (2007) 1.39
Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res (2000) 1.37
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res (2009) 1.35
Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res (2007) 1.29
Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. Int J Cancer (2008) 1.28
The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Urology (2005) 1.25
Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol (2003) 1.24
Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) (2009) 1.22
Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med (1997) 1.21
Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine (2002) 1.19
Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J Diabetes (2010) 1.19
Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway. Oncol Rep (2012) 1.19
Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators. Biochem Biophys Res Commun (2001) 1.17
Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs (2004) 1.17
Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer (1991) 1.16
Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Increased expression of NF-kappa B subunits in human pancreatic cancer cells. J Surg Res (2004) 1.15
Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids (2003) 1.14
Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol (2008) 1.13
Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. Biochem Pharmacol (2011) 1.12
Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res (2008) 1.11
Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clin Cancer Res (2000) 1.10
Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev (2001) 1.10
Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res (2010) 1.10
Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur J Cancer Prev (1999) 1.09
Antitumour principles from Nigella sativa seeds. Cancer Lett (1992) 1.08
Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol (2004) 1.07
Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur J Pharmacol (2006) 1.07
Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Res Commun Mol Pathol Pharmacol (2001) 1.06
Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int (1999) 1.06
Screening for high risk human papilloma virus (HR-HPV) subtypes, among Sudanese patients with oral lesions. Int J Clin Exp Med (2013) 1.06
Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int J Immunopathol Pharmacol (2003) 1.05
Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer (1992) 1.05
A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis. Biochem Biophys Res Commun (1999) 1.05
Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol (2002) 1.04
The growth-regulatory role of p21 (WAF1/CIP1). Prog Mol Subcell Biol (1998) 1.03
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS One (2013) 1.03
Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase. J Cell Physiol (2005) 1.03
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol (2011) 1.03
Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma. Int J Clin Exp Pathol (2012) 1.02
Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J Agric Food Chem (2004) 1.01
Signal transducers and activators of transcription-from cytokine signalling to cancer biology. Biochim Biophys Acta (2011) 1.01
Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Altern Med (2011) 1.00
Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer (2000) 1.00
Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol (2007) 1.00
Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer (2010) 1.00
Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. Cancer Res (2009) 1.00
Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase. J Cell Physiol (2003) 1.00
Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol (2011) 1.00
Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. Br J Pharmacol (2010) 1.00
Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib Med Chem (2004) 0.98
Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med (2011) 0.97
In vitro toxicological properties of thymoquinone. Food Chem Toxicol (2008) 0.97
Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. J Cell Biochem (2011) 0.96
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. Pharm Res (2010) 0.96
Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett (2006) 0.96
Effect of Nigella sativa (N. sativa L.) and oxidative stress on the survival pattern of MCF-7 breast cancer cells. Biomed Sci Instrum (2003) 0.96
Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytother Res (2009) 0.95
Cassia fistula Linn: Potential candidate in the health management. Pharmacognosy Res (2015) 0.75
Potential Antitumor Effects of Pomegranates and Its Ingredients. Pharmacogn Rev (2017) 0.75